Leucovorin Enhances the Anti-cancer Effect of Bortezomib in Colorectal Cancer Cells
Abstract Colorectal cancer is a major cancer type worldwide. 5-fluorouracil, often given with leucovorin, is the most commonly used drug in colorectal cancer chemotherapy, yet development of drug resistance to 5-fluorouracil in colorectal cancer cells is the primary cause of chemotherapy failure. Mo...
Guardado en:
Autores principales: | Shu Wang, Lei Wang, Zhiyang Zhou, Qipan Deng, Ling Li, Mingzhi Zhang, Linlin Liu, Yong Li |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7e6684641dae4958a4e0e768366c3204 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The essential role of TAp73 in bortezomib-induced apoptosis in p53-deficient colorectal cancer cells
por: Yasamin Dabiri, et al.
Publicado: (2017) -
Magnetic fluid hyperthermia enhances cytotoxicity of bortezomib in sensitive and resistant cancer cell lines
por: Alvarez-Berríos MP, et al.
Publicado: (2013) -
Evaluation of Antiemetic Therapy for Hepatic Arterial Infusion Chemotherapy with Oxaliplatin, Fluorouracil, and Leucovorin
por: Zhao Y, et al.
Publicado: (2021) -
Enhanced anti-cancer activity of andrographis with oligomeric proanthocyanidins through activation of metabolic and ferroptosis pathways in colorectal cancer
por: Tadanobu Shimura, et al.
Publicado: (2021) -
Exploration of Xanthone Derivatives as Anti-Cancer Agents against Colorectal Cancer
por: Isnatin Miladiyah
Publicado: (2020)